In the course of our searching program for novel antitumor antibiotics from microorganisms, a Streptomycete, isolated from a soil sample collected in Ichikawa City, Chiba Prefecture, Japan, was found to produce potent antitumor antibiotics, saptomycins, closely related to the pluramycin-group. A further investigation resulted in an interesting observation that the producing strain, named Streptomyces sp.
HP530, mutated frequently and the natural mutant produced several new compounds found in HPLC analysis. Saptomycins A, B, C1? C2, F and /?-indomycinone were detected in and purified from the mycelial cake of the parent strain. On the other hand, saptomycins D, E1}, G and Hwere isolated from the mutant. In this paper, we describe the taxonomic studies of the producing organism, fermentation, HPLCanalysis and biological activities. Isolation, physico-chemical properties and structure elucidation will be described in the following paper2'3).
Materials and Methods

Taxonomic Studies
Morpholgical and physiological properties of the strain were examined according to Shirling and Gottlieb40. Cell wall analysis was performed by the methods of Becker et al.5 ) and Yamaguchi6). The utilization of carbon sources was tested by growth on Pridham and Gottlieb's medium7) .
Fermentation
This strain mutated naturally and frequently. One of the natural mutants was used in this study. Both the parent and the mutant strains were cultured under the same conditions in seed culture. The seed medium consisting of glucose 0.5%, oatmeal 3.0%, Pharma media 1.0%, MgSO4-7H2O 0.5%, CoCl2-2H2O 0.002% and CaCO3 0.3%, was adjusted to pH 7.0 and sterilized at 121°C for 15 minutes in a 500-ml Erlenmeyer flask containing 100 ml of medium. Freeze dried vegetative mycelium was inoculated into this flask, which was incubated at 30°C for 4 days as the primary seed culture. Twenty ml of the seed culture was inoculated into each of three 3 liter-Erlenmeyer flasks containing 500ml of the above medium. After cultivating at 30°C for 4 days, 3% inoculum of the second seed was transferred to each 
HPLC Analysis
Each 20ml sample of the cultured broth, into which either the parent strain or the mutant was inoculated, was centrifuged at 3,000 rpm for 15 minutes. The mycelial cake, except for the supernatant liquid, was soaked in 20ml of acetone for 30 minutes and then recentrifuged at 3,000rpm for 15 minutes. The cultured supernatant was filtered and evaporated in vacuo. The concentrated acetone extract was dissolved in 20ml of H2Oand then extracted with 40ml of ethyl acetate. The ethyl acetate extract concentrated in vacuo was dissolved in 1.0ml of methanol and used for HPLCanalysis. HPLCanalysis was performed using an analytical column Capcell pak C18 SG120 (4.6 x 250mm, Shiseido Co. Ltd., Tokyo, Japan), elution with 0.15% KH2PO4(pH 3.5) -methanol (6 : 4 to 2 : 8 linear gradient for 20 minutes and then isocratic elution with 2 : 8 for 40 minutes), at a flow rate of 1.0ml/minute and detection at 395 nm.
Antimicrobial Activity MICvalues were determined by the agar dilution method. Heart infusion agar was used for bacteria and potato dextrose agar for yeasts.
Cytotoxic and Antitumor Activities
In vitro cytotoxicity tests using microculture tetrazolium assay (MTTassay)8) were performed with 6 human and 2 murine tumor cell lines. HumanMKN45 and MKN74 cells were gift from Dr. H. Hojo of Niigata University9). Human WiDr10) and SW481 1} cells were purchased from Dainippon Pharmaceutical Co. (Osaka, Japan). Human PC-312), A54913) and murine P38814) cells were obtained from JCRB. Meth A15) cells were gift from Dr. H. Sato of Sasaki Institute. All cells were maintained in RPMI1640 medium supplemented with 10%fetal bovine serum. The IC50 value was calculated with Probit's method.
The antitumor activities of these compoundswere evaluated in an experimental tumor system in mice bearing Meth A. Cells were implanted intraperitoneally into CDFXmice (female, 6 weeks old, purchased from Charles River Japan, Inc., Atugi, Japan) at an inoculum size of 1 x 106 cells per mouse. Drugs were The color index in the parenthesis ( ) is in accordance with ISCC-NBSColor-Name Chart and represents the result of observation on the second week at 28°C on each medium.
given ip daily from day 1 to day 4. Each group consisted of 6 mice. Negative and positive control mice received physiological saline and 5FU, respectively. Survival or death of the treated mice was recorded during the experimental period of 4 weeks. The mediam survival time of each test group was calculated.
Results and Discussion
Taxonomic Studies of the Producing Strain The strain HP530producing saptomycins was cultured in various ISP media and the characteristics are summarized in Table 1 . Substrate mycelia were well developed in the media and tested without fragmentation. Aerial mycelia formed abundantly on various madia appeared yellow to white. A spore chain with 10 to 50 spores was observed to be straight to flexuous. Spores were cylindical in shape with a size of 0.6 x 1.2/im and their surface was smooth. Sclerotia, sporangia and zoospores were not observed. The physiological characteristics and the utilization of carbohydrates observed after incubation at 28°C for 14 days are shown in Tables 2 and 3, respectively. The soluble pigment was brown to orange on peptone -yeast extract agar. Whole cell hydrolysates of the strain HP530contained L,L-diaminopimelic acid. The strain was placed in the type I cell wall group. On the basis of the observations described 
Fermentation
The fermentations of saptomycins were carried out as described in Materials and Methods. A typical Fig. 3 . HPLC profile of products.
Column: Capcell pak C18 SG120 (4.6x250mm). Solvent: 0.15% KH2PO4 (pH 3.5)-CH3OH 6:4-2: 8 (20minutes linear gradient), and then 2:8 (40 minutes).
Flow rate: 1.0ml/minute. Detection: UV 395nm.
Saptomycin F was eluted at 50minutes in both analyses, thus the peak of this compound did not appear on these charts. a Recombination deficient. OCT. 1993 time course of the fermentation is shown in Fig. 1 and Fig. 2 . The monitoring of saptomycin production was performed using HPLCanalysis. The production of saptomycins reached a maximumat 72 hours after inoculation with the parent or the mutant strain. HPLCAnalysis The HPLCprofile of saptomycin production is shown in Fig. 3 . The parent strain yielded saptomycins A, B, Cl9 C2, F and /?-indomycinone, while the mutant gave saptomycins A, D, E, F, G, H and pindomycinone as products. The resulting profile of the analysis indicated the different patterns of production between the parent and the mutant. 
Antitumor Activities
In vitro antitumor activities of saptomycins against various cell lines are shown in Table 5 . All saptomycins except saptomycin A exhibited growth inhibitory activity in a dose dependent manner (data not shown). Saptomycins D, E and H showed especially strong activity. The effects of saptomycins on Meth A fibrosarcoma implanted in mice are shown in Table 6 . Saptomycins Cl9 C2, D and E were remarkable for their clear increase in life span.
